What You Can Expect From the Pandemic in 2021

NYSE: SPY | SPDR S&P 500 ETF Trust News, Ratings, and Charts

SPY – Today’s article features the SPY, Moderna (MRNA), and Pfizer (PFE), revealing what investors can expect from the pandemic in 2021. Read for details.

2020 will go down in history as one of the most volatile years in history, courtesy of the coronavirus that resulted in the worst pandemic in over a century.

(Source: Jill Mislinksi) 

The S&P 500 plunged 34% in a single month and then saw two months of double-digit gains, as well as the strongest best market rally in history. Much of this market action was a direct result of how the pandemic was going, and the economic response to it.

Last week I explained the risks of the new UK super strain of the virus, which is between 40% and 70% more transmissible. In this two-part series, I wanted to explain what the world’s leading health experts expect from the pandemic in 2021, and what that likely means for the economy, corporate fundamentals, and your portfolio.

Because if you know what’s most likely to happen, about the most important fundamental in the world right now, then you have the best chances of avoiding costly mistakes and profiting from the best blue-chip bargains on Wall Street. The names that are most likely to rise like a Phoenix from the ashes of this recession and soar to new heights.

Vaccine Update: The Most Important Component To A 2021 Recovery

Nothing other than vaccines and achieving herd immunity (70% to 85% national immunity) will end this pandemic.

(Source: NYT)

  • 149 total vaccines in development
  • 64 in human trials
  • 3 already approved (2 approved in the US and Europe)

AstraZeneca’s vaccine is expected to be approved in the UK in the next week.

JNJ’s one-shot vaccine, the first single-dose vaccine, is expected to be approved in February.

This is the estimated timeline for vaccine distribution in the US. It’s primarily based on the estimates from pharma companies about how quickly they can ramp up vaccine production.

However, we can’t forget there are many steps beyond just producing a vaccine that could hamper the speed of the rollout.

(Source: NYT)

  • 10 million US vaccinations were expected by the end of the year.
  • we’re currently 81% below that goal
  • logistical constraints are proving worse than anticipated (and we anticipated lots of them)

Many states are reporting receiving vaccine allocations 40% below those initially expected.

(Source: NYT)

And even when they have vaccines available, most states are taking much longer to ramp up actual vaccination programs.

In other words, it’s possible that the pandemic will peak soon, or get worse for another few weeks.

For example, here’s what healthcare experts predict for the first quarter of the year.


Scientists will be watching closely for signs that the first vaccine distributions, which have been reserved for some of the most essential workers and vulnerable adults, help to blunt the spread of the virus more broadly in communities around the country.

Researchers still don’t know whether coronavirus vaccines prevent people from getting infected, only that they are good at preventing severe disease, so it may be a while before transmission slows down.

“I’m still making everybody wear masks at work, whether or not they’re vaccinated,” said Dr. Alice Sato, an epidemiologist at Children’s Hospital & Medical Center in Omaha, Nebraska.” – Business Insider


Vaccines continue for priority groups including frontline workers and Americans over age 65. As many as 100 million Americans could be vaccinated by the end of February.

Moderna’s and Pfizer’s vaccines require two shots given three or four weeks apart, so the only people with full-scale protection at this point will be those who got their second vaccine dose in January.

Doctors don’t expect the first months of 2021 to look much different from the end of 2020.

“People think, ‘Oh, the vaccine is here, then everything is over.’ No. A vaccine is not vaccination,” said Dr. Ricardo Correa, an endocrinologist at the University of Arizona College of Medicine.” – Business Insider


Bars remain closed. Indoor celebrations threaten to increase transmission.

Vaccines are expected to have reached roughly 100 million Americans, and priority groups are likely expanding to include people under 65 with preexisting conditions.

Each state may decide a little differently who’s first in line for their shots, but generally the priority groups include healthcare workers, people over 65, frontline workers, and people with preexisting conditions.

Michael Osterholm, President-elect Joe Biden’s COVID-19 advisor and director of the Center for Infectious Disease Research and Policy at the University of Minnesota, said he would be waiting at home for his vaccine, likely until in the spring.

“I will not budge in line; there’s others who need to get this vaccine well before me,” he said. “But the very second — the very second — my number comes up, I’m there.”

Osterholm is 67 years old, so he’s in one of the priority groups for vaccination.

“I’m going to get mine at my healthcare provider, and when my number comes up, I’ll be there 10 minutes early,” he said.” – Business Insider

US Pandemic Update: Most Likely Close To Peak Suck, But Things Could Still Get A Lot Worse If We Get Complacent

(Source: NYT)

US daily cases may have peaked if IHME is correct. We also may have peaked in terms of hospitalizations, which peaked at around 120,000 in the last week.

(Source: IHME)

IHME estimates we may have peaked in new infections on Christmas Eve (about 700,000 infections).

  • the new strain + poor social distancing could push this back several weeks, to the end of January (up to 1.4 million infections)

(Source: IHME)

IHME estimates a peak of about 3,900 deaths on January 11th (up from 3,800 on January 6th last week)

  • which assumes April levels of social distancing (53% less social mobility vs pre-pandemic levels)
  • -24% social mobility on December 14th (holiday travel)
  • if we maintain that level of social distancing then daily deaths expected to peak around February 10th at 5,500 (possibly as high as 7,000)

(Source: IHME)

The US is expected to see 567,000 total dead by April 1st (up 5,000 since last week)

  • if social distancing remains at current levels as many as 811,000 (up about 11K from last week’s forecast)

The Super Strain of the virus, if it’s in the US (I and numerous health experts, including Dr. Osterholm, expect it is) will start to show up in daily case data in early January.

  • it takes 14 to 21 days from infection until new confirmed cases are reported
  • and another 17 to 21 days for deaths to start rising

In part two of this series, I’ll explain what the likely end of the pandemic in 2021 means for the US economy, corporate earnings, and how to profit from what JPMorgan expects could potentially be one of the best years for stocks in decades.

SPY shares were trading at $368.13 per share on Monday morning, down $5.75 (-1.54%). Year-to-date, SPY has declined -1.54%, versus a % rise in the benchmark S&P 500 index during the same period.

About the Author: Adam Galas

Adam has spent years as a writer for The Motley Fool, Simply Safe Dividends, Seeking Alpha, and Dividend Sensei. His goal is to help people learn how to harness the power of dividend growth investing. Learn more about Adam’s background, along with links to his most recent articles. More...

More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
SPYGet RatingGet RatingGet Rating
MRNAGet RatingGet RatingGet Rating
PFEGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com

:  |  News, Ratings, and Charts

7 Simple Strategies to Beat the Market

Steve Reitmeister has been investing successfully for over 40 years. In his new presentation he shares his top 7 strategies learned over the years to help investors beat the stock market (SPY). Discover these strategies now to improve your investing results in the months and years to come.

:  |  News, Ratings, and Charts

AutoNation: A Great Value Stock

Shortages in parts, especially semiconductors, this year, has been a boon to auto dealerships. Consumers resorted to buying used cars and parts, which benefits a company such as AutoNation, Inc. (AN). The stock has seen strong revenue growth and share gains this year. Since AN is still very much undervalued, there is a lot more upside left for investors.

:  |  News, Ratings, and Charts

Go From Zero to 60 with a Still-Early-Stage Stake in Fisker

Admittedly, it took a long time for Fisker (FSR) to unveil its all-electric SUV. With that event now completed, FSR stock is prepped for a rally.

:  |  News, Ratings, and Charts

Bull Market Update: Year End Targets?

4,700 seems to be a point of serious resistance for the S&P (SPY) leading to an extended consolidation period hand in hand with violent sector rotation. Why is this happening? What happens next? And how to trade this environment? The answer to these questions and more are discussed in this market commentary below...

:  |  News, Ratings, and Charts

Go From Zero to 60 with a Still-Early-Stage Stake in Fisker

Admittedly, it took a long time for Fisker (FSR) to unveil its all-electric SUV. With that event now completed, FSR stock is prepped for a rally.

Read More Stories

More SPDR S&P 500 ETF Trust (SPY) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All SPY News